Drug factory · FDA FEI 3002561809

Corden Pharma Switzerland LLC

Eichenweg 1, Liestal, Switzerland

Switzerland: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 14, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2011: 2 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
EliglustatMakes the active ingredient and tests it Genzyme Corporation 58468-0220

FDA inspection history

EndedResultProgramProblems noted
Jun 14, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 2, 2018No problems foundDrug Quality Assurance—
Jan 31, 2014No problems foundDrug Quality Assurance—
Dec 22, 2011Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.